scanX
Home
Syncom Formulations

Syncom Formulations

19.77
-0.41
(-2.03%)
Market Cap (₹ Cr.)
₹1,892
52 Week High
27.90
Book Value
₹3
52 Week Low
9.80
PE Ratio
57.51
PB Ratio
6.03
PE for Sector
41.94
PB for Sector
19.70
ROE
7.84 %
ROCE
12.89 %
Dividend Yield
0.00 %
EPS
₹0.30
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
15.93 %
Net Income Growth
26.13 %
Cash Flow Change
-156.60 %
ROE
12.06 %
ROCE
95.37 %
EBITDA Margin (Avg.)
8.79 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
44
40
51
47
49
44
48
46
49
42
40
41
41
34
46
49
63
55
57
54
45
30
67
85
69
53
56
59
64
54
57
59
68
61
66
68
76
88
106
Expenses
40
37
45
41
45
40
43
41
45
38
36
36
37
31
41
44
58
50
51
48
39
25
54
71
57
44
47
52
56
48
50
51
55
53
56
57
64
76
90
EBITDA
5
4
6
5
4
5
5
6
4
4
4
5
3
3
5
5
4
5
6
6
5
5
14
14
12
8
8
7
8
6
7
8
13
8
10
11
12
12
16
Operating Profit %
7 %
7 %
10 %
9 %
5 %
9 %
9 %
11 %
7 %
8 %
7 %
9 %
5 %
5 %
8 %
8 %
5 %
7 %
9 %
8 %
8 %
14 %
19 %
15 %
13 %
14 %
11 %
9 %
3 %
7 %
8 %
10 %
10 %
10 %
10 %
11 %
12 %
11 %
12 %
Depreciation
1
1
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
0
0
Profit Before Tax
4
3
5
5
4
4
4
5
3
3
3
4
2
2
4
4
3
4
5
5
4
4
13
13
11
7
7
6
6
5
5
6
10
6
8
9
9
10
15
Tax
2
1
2
2
1
1
1
2
-0
1
1
1
1
0
1
1
1
1
1
1
1
1
3
3
4
2
2
2
1
1
1
2
3
2
1
2
2
2
3
Net Profit
2
2
3
3
2
3
3
3
2
2
2
3
2
2
3
4
2
3
4
4
4
3
9
10
7
5
6
4
5
4
4
4
8
4
6
6
7
8
11
EPS in ₹
0.02
0.03
0.04
0.03
0.03
0.03
0.04
0.03
0.03
0.03
0.03
0.05
0.01
0.02
0.04
0.05
0.03
0.03
0.05
0.04
0.04
0.04
0.12
0.13
0.09
0.08
0.06
0.07
0.05
0.03
0.06
0.06
0.10
0.07
0.08
0.09
0.09
0.11
0.16
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
138
175
175
171
173
181
292
308
377
392
Fixed Assets
46
46
85
89
89
93
91
94
91
120
Current Assets
79
86
83
78
78
86
190
140
181
263
Capital Work in Progress
0
5
0
1
0
0
0
6
26
0
Investments
0
0
1
2
2
1
11
43
64
66
Other Assets
92
125
89
79
83
87
189
165
196
206
Total Liabilities
37
67
61
49
40
35
104
86
121
105
Current Liabilities
32
60
53
40
33
28
97
78
112
95
Non Current Liabilities
6
6
8
9
8
7
7
8
9
10
Total Equity
100
109
114
122
133
146
188
222
256
286
Reserve & Surplus
22
31
36
44
55
68
109
136
162
192
Share Capital
78
78
78
78
78
78
79
86
94
94
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
-1
6
-6
7
1
-5
-2
1
63
Investing Activities
1
-23
-8
-2
2
2
-75
-27
-45
84
Operating Activities
1
24
17
-2
4
6
-2
16
10
-6
Financing Activities
1
-2
-2
-2
-0
-7
72
8
35
-15
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
41.18 %
41.18 %
44.01 %
44.01 %
46.12 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
50.57 %
FIIs
0.00 %
0.00 %
0.58 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.08 %
0.09 %
0.10 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
58.82 %
58.82 %
55.40 %
55.99 %
53.88 %
49.43 %
49.43 %
49.43 %
49.43 %
49.43 %
49.43 %
49.43 %
49.43 %
49.35 %
49.34 %
49.33 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,101.95 1,04,737.39 60.19 10,785.75 11.59 1,656 17.36 35.93
Ajanta Pharma
2,945.50 36,719.79 41.97 4,293.31 11.77 816 10.84 45.45
Gland Pharma
1,787.00 29,300.27 42.36 5,834.96 50.97 772 -15.74 55.05
Eris Lifesciences
1,366.90 18,570.27 53.30 2,032.96 19.85 397 -21.22 57.19
Caplin Point Laboratories
1,942.80 14,832.16 30.05 1,761.04 15.65 461 12.63 48.70
Marksans Pharma
309.15 13,860.01 39.93 2,227.83 16.55 315 16.59 60.92
Shilpa Medicare
936.00 8,604.62 149.90 1,159.77 8.64 32 1,042.68 63.63
Jeena Sikho Lifecare
1,931.55 4,768.92 142.84 207.35 40.06 34 - 70.53
Amrutanjan Health Care
705.50 2,084.17 43.85 192.42 12.50 21 72.26 43.82
Hester Biosciences
2,381.90 2,073.08 88.33 315.18 12.07 21 107.67 45.73

Corporate Action

Technical Indicators

RSI(14)
Neutral
45.44
ATR(14)
Less Volatile
1.11
STOCH(9,6)
Neutral
29.05
STOCH RSI(14)
Neutral
32.41
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
14.98
UO(9)
Bearish
39.25
ROC(12)
Downtrend And Accelerating
-5.09
WillR(14)
Neutral
-70.43
Bearish
5
Neutral
4
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.